Themis Medicare Ltd Technical Momentum Shifts Amid Mixed Market Signals

Technical Trend Overview and Price Movement

The stock closed at ₹110.45 on 10 Aug 2026, down from the previous close of ₹112.65. Intraday price fluctuations ranged narrowly between ₹109.90 and ₹112.50, reflecting subdued volatility. Over the past 52 weeks, Themis Medicare’s price has oscillated between a low of ₹65.00 and a high of ₹147.99, indicating significant historical price swings. The current price sits approximately 25% below its 52-week peak, signalling a potential consolidation phase.

Comparatively, Themis Medicare’s returns have been mixed against the broader Sensex benchmark. Over the last week, the stock outperformed with a 4.99% gain versus Sensex’s 0.52%. However, monthly returns tell a different story, with the stock declining 5.32% while the Sensex rose 0.41%. Year-to-date, Themis Medicare has delivered a robust 9.74% return, outperforming the Sensex’s negative 7.89%. Longer-term returns, such as the three-year period, show a 32.06% decline against the Sensex’s 19.02% gain, highlighting challenges in sustained growth.

MACD and Momentum Indicators Signal Mixed Sentiment

The Moving Average Convergence Divergence (MACD) indicator presents a bullish signal on the weekly timeframe, suggesting upward momentum in the near term. The monthly MACD, however, is mildly bullish, indicating a less decisive trend over a longer horizon. This divergence between weekly and monthly MACD readings points to a potential transition phase where short-term optimism is tempered by longer-term caution.

The KST (Know Sure Thing) indicator aligns with this view, showing bullish momentum weekly and mildly bullish monthly, reinforcing the notion of a gradual positive shift in price momentum. Conversely, the Dow Theory readings introduce some caution, with a mildly bearish weekly signal and no clear monthly trend, underscoring the presence of conflicting forces in the market.

RSI and Bollinger Bands Reflect Neutral to Mixed Conditions

The Relative Strength Index (RSI) on both weekly and monthly charts currently offers no clear signal, hovering in neutral territory. This suggests that the stock is neither overbought nor oversold, leaving room for directional movement based on upcoming market catalysts.

Bollinger Bands add further nuance: weekly readings are bullish, indicating price strength and potential for upward breakout, while monthly bands are mildly bearish, hinting at possible resistance or volatility ahead. This contrast between short- and long-term volatility measures suggests investors should monitor price action closely for confirmation of trend direction.

Moving Averages and On-Balance Volume Support Mildly Bullish Outlook

Daily moving averages present a mildly bullish stance, with the stock price maintaining levels above key short-term averages. This technical positioning often signals a tentative uptrend, albeit with limited conviction. The On-Balance Volume (OBV) indicator supports this view, showing bullish momentum on both weekly and monthly scales, implying that buying pressure is gradually increasing despite recent price softness.

Market Capitalisation and Mojo Grade Evolution

Themis Medicare is classified as a micro-cap stock, reflecting its relatively modest market capitalisation within the Pharmaceuticals & Biotechnology sector. The company’s Mojo Score currently stands at 53.0, a moderate rating that recently improved from a previous Sell grade to a Hold as of 30 Jun 2026. This upgrade signals a cautious but positive reassessment of the company’s prospects by technical analysts, suggesting that while risks remain, the stock may be stabilising after prior weakness.

Investors should note that the Hold rating implies neither a strong buy nor a sell recommendation, but rather a wait-and-watch approach pending clearer directional cues from the market and company fundamentals.

Comparative Performance and Sector Context

Within the Pharmaceuticals & Biotechnology sector, Themis Medicare’s technical signals are somewhat reflective of broader industry volatility. The sector often experiences fluctuations driven by regulatory developments, research outcomes, and market sentiment towards healthcare innovation. The stock’s recent technical shift to mildly bullish aligns with a tentative recovery phase, although the mixed signals from monthly indicators counsel prudence.

Relative to the Sensex, Themis Medicare’s performance has been uneven. While short-term gains outpace the benchmark, longer-term returns lag significantly, underscoring the challenges faced by micro-cap pharmaceutical firms in sustaining growth amid competitive pressures and market uncertainties.

Investor Takeaways and Outlook

For investors considering Themis Medicare Ltd, the current technical landscape suggests a cautiously optimistic stance. The mildly bullish weekly MACD and KST indicators, supported by bullish OBV readings, point to underlying buying interest and potential for price appreciation in the near term. However, the absence of strong RSI signals and the mildly bearish monthly Bollinger Bands advise vigilance against possible volatility or resistance levels.

Given the stock’s micro-cap status and mixed long-term returns, investors should weigh these technical signals alongside fundamental factors such as earnings performance, regulatory developments, and sector dynamics. The recent upgrade from Sell to Hold by MarketsMOJO reflects this balanced view, recommending monitoring for confirmation of sustained momentum before committing to significant positions.

In summary, Themis Medicare Ltd’s technical indicators reveal a stock in transition, with short-term momentum improving but longer-term trends still uncertain. This nuanced picture calls for a measured approach, favouring selective accumulation with appropriate risk management.

Summary of Key Technical Metrics:

• Current Price: ₹110.45 (10 Aug 2026)
• Day Change: -1.95%
• 52-Week Range: ₹65.00 - ₹147.99
• MACD: Weekly Bullish, Monthly Mildly Bullish
• RSI: No Signal (Weekly & Monthly)
• Bollinger Bands: Weekly Bullish, Monthly Mildly Bearish
• Moving Averages: Daily Mildly Bullish
• KST: Weekly Bullish, Monthly Mildly Bullish
• Dow Theory: Weekly Mildly Bearish, Monthly No Trend
• OBV: Weekly & Monthly Bullish
• Mojo Score: 53.0 (Hold, upgraded from Sell on 30 Jun 2026)

Performance Comparison with Sensex:

• 1 Week: +4.99% vs Sensex +0.52%
• 1 Month: -5.32% vs Sensex +0.41%
• Year-to-Date: +9.74% vs Sensex -7.89%
• 1 Year: -4.33% vs Sensex -2.63%
• 3 Years: -32.06% vs Sensex +19.02%
• 5 Years: +12.44% vs Sensex +44.63%
• 10 Years: +115.26% vs Sensex +179.57%

Investors should continue to monitor Themis Medicare’s technical indicators alongside broader market and sector developments to gauge the sustainability of its current momentum.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today